SEC Form SC 13G filed by Select Medical Holdings Corporation
$SEM
Hospital/Nursing Management
Health Care
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/25/2024 | Buy → Hold | The Benchmark Company | |
| 8/20/2024 | $42.00 | Buy | BofA Securities |
| 3/7/2022 | $47.00 → $42.00 | Outperform | RBC Capital |
| 1/18/2022 | $40.00 → $35.00 | Buy | B of A Securities |
| 1/18/2022 | $50.00 → $47.00 | Outperform | RBC Capital |
| 8/10/2021 | $37.00 → $39.00 | Neutral | Credit Suisse |
The Benchmark Company downgraded Select Medical from Buy to Hold
BofA Securities resumed coverage of Select Medical with a rating of Buy and set a new price target of $42.00
RBC Capital reiterated coverage of Select Medical Holdings with a rating of Outperform and set a new price target of $42.00 from $47.00 previously
MECHANICSBURG, Pa., Dec. 3, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE:SEM), today announced that Select Medical Corporation, a wholly-owned subsidiary of Holdings ("Select"), has completed a private offering (the "Offering") of $550.0 million in aggregate principal amount of its 6.250% senior notes due 2032 (the "notes"). The notes are senior unsecured obligations of Select and are guaranteed by certain of Select's existing and future domestic subsidiaries. Select used the net proceeds of the Offering, together with the proceeds from the new incremental term loan and cash on hand, to repay in full the term loans currently outstanding under Select's existing
MECHANICSBURG, Pa., Nov. 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced that we have completed our previously announced distribution (the "Distribution") of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Distribution, Select Medical no longer owns any shares of Concentra's common stock. The Distribution was made today to Select Medical's stockholders as o
Concentra Group Holdings Parent, Inc. ("Concentra," "we," "us," or "our") (NYSE:CON) today announced that Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) has completed its previously announced distribution (the "Distribution") of 104,093,503 shares of Concentra's common stock owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Distribution, Select Medical no longer owns any shares of Concentra's common stock. The Distribution was made today to Select Medical's stockholders as of the close of business on November 18, 202
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
MECHANICSBURG, Pa., Oct. 1, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2024 on Thursday, October 31, 2024 after the market closes. Select Medical will host a conference call regarding its third quarter results, as well as its business outlook, on Friday, November 1, 2024, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For
MECHANICSBURG, Pa., July 12, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced an estimate of certain financial results of its wholly-owned subsidiary, Concentra Group Holdings Parent, Inc. ("Concentra"), for the second quarter ended June 30, 2024 in advance of the announcement of Select Medical's actual results, which is expected to occur after market close on Thursday, August 1, 2024. Select Medical expects Concentra's net operating revenue for its second quarter of 2024 to be approximately $477.9 million. Select Medical expects Concentra's income from operations for the second quarter of 2024 to be approximately $
MECHANICSBURG, Pa., June 28, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its second quarter ended June 30, 2024 on Thursday, August 1, 2024 after the market closes. Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 2, 2024, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listene
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin
MECHANICSBURG, Pa., Nov. 2, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors (the "Board"), effective on November 1, 2021. Dr. Khanuja's Board term will expire at Select Medical's 2023 Annual Meeting of Stockholders, at which time he will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Dr. Khanuja to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Dr. Khanuja brings to Select Medical over three decades of experi
MECHANICSBURG, Pa., April 16, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Katherine R. Davisson to its Board of Directors (the "Board"), effective immediately. Ms. Davisson's Board term will expire at Select Medical's 2022 Annual Meeting of Stockholders, at which time she will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Katherine Davisson to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Ms. Davisson brings to Select Medical over two decades of financial servi
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
144 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)